Cell Systems

Cell Systems is a premier provider of primary human cells and specialized cell culture media for the global research community. Established in 1989, the company focuses on the isolation and characterization of high-quality primary cells, including endothelial, epithelial, and smooth muscle cells. Their products are essential for drug discovery, toxicology testing, and basic biological research, providing standardized models that closely mimic in vivo conditions. The company's portfolio includes proprietary media formulations designed to maintain cell phenotype and function across various experimental conditions. In 2022, the company was acquired by Molecular Devices, a Danaher company, integrating its cell biology expertise into a broader portfolio of life science solutions.